LifeStance director granted 17,746 RSUs

LifeStance Health Group, Inc. director Sarah Personette received an equity grant of common stock.

Accepted by SEC EDGAR 07/07/2026 - 07:40 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

LifeStance Health Group, Inc. director Sarah Personette received an equity grant of common stock. She acquired 17,746 shares at a stated price of $0.00 per share as a grant, increasing her direct holdings to 92,512 shares of common stock.

The grant includes 17,746 restricted stock units (RSUs), and each RSU represents a contingent right to receive one share of LifeStance common stock. This is a compensation-related award rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 17,746 shares

Grant/Award 1 txn

Insider Personette Sarah

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	17,746	$0.00	$0.00

Holdings After Transaction: Common Stock — 92,512 shares (Direct)

Footnotes (1)

1. F1. Includes 17,746 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Key Figures

RSU grant size: 17,746 shares Grant price: $0.00 per share Post-transaction holdings: 92,512 shares +1 more

4 metrics

RSU grant size 17,746 shares Restricted stock units granted to Sarah Personette

Grant price $0.00 per share Stated price for the awarded common stock

Post-transaction holdings 92,512 shares Total direct common stock held after the grant

RSU-to-share ratio 1 RSU : 1 share Each RSU represents one LifeStance common share

Key Terms

restricted stock units ("RSUs"), contingent right, Common Stock, Grant, award, or other acquisition

4 terms

restricted stock units ("RSUs") financial

"Includes 17,746 restricted stock units ("RSUs"). Each RSU represents a contingent right"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

contingent right financial

"Each RSU represents a contingent right to receive one share of the Issuer's common stock."

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did LifeStance Health Group (LFST) director Sarah Personette report on this Form 4?

Sarah Personette reported an equity grant of 17,746 shares of LifeStance common stock. The award was recorded at a price of $0.00 per share and reflects a compensation-related grant, not an open-market stock purchase or sale.

How many LifeStance (LFST) shares does Sarah Personette hold after this transaction?

After the award, Sarah Personette directly holds 92,512 shares of LifeStance common stock. This total includes the 17,746 restricted stock units reported in the filing, each representing a contingent right to receive one share of common stock.

Was cash paid for the LifeStance (LFST) shares in Sarah Personette’s Form 4 filing?

No cash payment was indicated for this transaction; the shares were granted at a stated price of $0.00 per share. This confirms it is a compensation-related grant rather than a market purchase funded with cash.

What are the 17,746 RSUs disclosed for LifeStance (LFST) director Sarah Personette?

The filing states that 17,746 of the reported shares are restricted stock units (RSUs). Each RSU gives a contingent right to receive one LifeStance common share, typically subject to vesting or other service and performance conditions.

Does this LifeStance (LFST) Form 4 show any stock sales by Sarah Personette?

The Form 4 does not report any stock sales by Sarah Personette. It only shows an acquisition coded as a grant or award, increasing her direct holdings of LifeStance common stock through RSUs and related share awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Personette Sarah

(Last) (First) (Middle)

C/O LIFESTANCE HEALTH GROUP, INC.

4800 N. SCOTTSDALE ROAD, SUITE 2500

(Street)

SCOTTSDALE ARIZONA 85251

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/02/2026		A		17,746(1)	A	$0.00	92,512	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 17,746 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

	By: /s/ Ryan Pardo, Attorney-in-Fact	07/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)